Commentary - Pharmaceutical Executive

ADVERTISEMENT

Commentary

Copay Cards and Coupons: Letting the Facts Get in the Way

January 1, 2012

Mason Tenaglia offers empirical defense of coupons and copay offset programs.

Giving Press Releases New Legs

August 1, 2011

Social media now gives companies a plethora of creative ways to digitally spread recent company news and keep customers informed

UK Stakeholders Have Their Say on Value-Based Pricing

May 1, 2011

The UK coalition government's consultation on the intro of value-based pricing has invited caution and resistance

Restoring Public Trust in Pharma

April 1, 2011

GSK's Deirdre Connelly puts the focus on four steps to cement a new compliance culture

A New Twist in the Cost Curve

December 1, 2010

The strict regulatory divide between market authorization and price reimbursement iscrumbling in the US. Is industry prepared to adapt or challenge?

Boundaries of Expanded Access

May 1, 2008

More patients are demanding drugs--and showing up everywhere form YouTube to the Supreme Court. But to offer access to investigational drugs, companies first need to know the rules

Putting the "I" in "Team"

April 1, 2008

Pharma is embracing the cross-functional team. But that doesn't mean that you must blend in with the sheep. Putting your best foot forward strengthens the team...and you.

Earning the Public Trust—and Keeping It

March 1, 2008

The industry needs credibility with consumers to make a spoonful of risk go down. So how does pharma speak to top concerns?

ADVERTISEMENT

Click here